William Thomas Creasman

Title
InstitutionMedical University of South Carolina
DepartmentGynecologic Oncology
AddressP.O. Box MSC 619
634
96 Jonathan Lucas St.
Phone843-792-4500
Fax843-792-0533
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Women-s Health, Cancer, Cancer/Gynecological

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hagemann IS, Deng W, Zaino RJ, Powell MA, Gunderson C, Cosgrove C, Mathews C, Pearl ML, Waggoner S, Ghebre R, Lele S, Guntupalli S, Secord AA, Ioffe O, Park K, Rasty G, Singh M, Soslow R, Creasman W, Mutch DG. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. Gynecol Oncol. 2021 Mar; 160(3):660-668. PMID: 33423806.
      Citations:    
    2. Hoffman MS, Chi DS, Clarke-Pearson DL, Cliby W, Creasman W, Underwood PB. Surgical training in gynecologic oncology: Past, present, future. Gynecol Oncol. 2020 07; 158(1):188-193. PMID: 32456991.
      Citations:    
    3. Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study. Am J Obstet Gynecol. 2018 11; 219(5):459.e1-459.e11. PMID: 30096321.
      Citations:    
    4. Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT, Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol Oncol. 2018 01; 148(1):174-180. PMID: 29132872.
      Citations:    
    5. Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. Int J Cancer. 2018 03 15; 142(6):1102-1115. PMID: 29063589.
      Citations:    
    6. Devor EJ, Miecznikowski J, Schickling BM, Gonzalez-Bosquet J, Lankes HA, Thaker P, Argenta PA, Pearl ML, Zweizig SL, Mannel RS, Brown A, Ramirez NC, Ioffe OB, Park KJ, Creasman WT, Birrer MJ, Mutch D, Leslie KK. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 12; 147(3):648-653. PMID: 28969912.
      Citations:    
    7. Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF, Burger RA, Thigpen JT, Birrer MJ, Waggoner SE, Moore DH, Look KY, Koh WJ, Monk BJ. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017 Oct 07; 390(10103):1654-1663. PMID: 28756902.
      Citations:    
    8. Buchanan T, Pierce JY, Graybill W, Kohler M, Creasman W. Why do we continue to overtreat stage Ia carcinoma of the cervix? Am J Obstet Gynecol. 2017 10; 217(4):413-417. PMID: 28522321.
      Citations:    
    9. Creasman WT, Ali S, Mutch DG, Zaino RJ, Powell MA, Mannel RS, Backes FJ, DiSilvestro PA, Argenta PA, Pearl ML, Lele SB, Guntupalli SR, Waggoner S, Spirtos N, Boggess JF, Edwards RP, Filiaci VL, Miller DS. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol. Gynecol Oncol. 2017 06; 145(3):519-525. PMID: 28392124.
      Citations:    
    10. Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. J Natl Cancer Inst. 2017 03 01; 109(3):1-10. PMID: 28376204.
      Citations:    
    11. Pereira E, Cooper HH, Zelaya PG, Creasman W, Price FV, Gupta V, Chuang L. Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting. Gynecol Oncol Rep. 2017 Feb; 19:50-52. PMID: 28116341.
      Citations:    
    12. Winder AD, Maniar KP, Wei JJ, Liu D, Scholtens DM, Lurain JR, Schink JC, Buttin BM, Filiaci VL, Lankes HA, Ramirez NC, Park K, Singh M, Lieberman RW, Mannel RS, Powell MA, Backes FJ, Mathews CA, Pearl ML, Secord AA, Peace DJ, Mutch DG, Creasman WT, Kim JJ. Synuclein-? in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study. Cancer. 2017 04 01; 123(7):1144-1155. PMID: 27926776.
      Citations:    
    13. Rose PG, Java JJ, Morgan MA, Alvarez-Secord A, Kesterson JP, Stehman FB, Warshal DP, Creasman WT, Hanjani P, Morris RT, Copeland LJ. Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Dec; 143(3):511-515. PMID: 27692669.
      Citations:    
    14. Neal SA, Graybill WS, Garrett-Mayer E, McDowell ML, McLean VE, Watson CH, Pierce JY, Kohler MF, Creasman WT. Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases? Gynecol Oncol. 2016 08; 142(2):278-82. PMID: 27261326.
      Citations:    
    15. Chuang L, Kanis MJ, Miller B, Wright J, Small W, Creasman W. Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries. Am J Clin Oncol. 2016 Feb; 39(1):92-7. PMID: 26398064.
      Citations:    
    16. Rocconi RP, Lankes HA, Brady WE, Goodfellow PJ, Ramirez NC, Alvarez RD, Creasman W, Fernández JR. The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Feb; 140(2):264-9. PMID: 26603970.
      Citations:    
    17. Felix AS, Scott McMeekin D, Mutch D, Walker JL, Creasman WT, Cohn DE, Ali S, Moore RG, Downs LS, Ioffe OB, Park KJ, Sherman ME, Brinton LA. Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial. Gynecol Oncol. 2015 Oct; 139(1):70-6. PMID: 26341710.
      Citations:    
    18. Felix AS, Brinton LA, McMeekin DS, Creasman WT, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R, Sherman ME. Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. J Natl Cancer Inst. 2015 Sep; 107(9). PMID: 26089540.
      Citations:    
    19. Chuang L, Moore KN, Creasman WT, Goodman A, Henriquez Cooper H, Price FV, Conner MG, Gupta V, Gallion HH, Husseinzadeh N, Duarte J, Vu QH, Sanchez JA, Kanis MJ. Teaching gynecologic oncology in Low resource settings: a collaboration of health volunteers overseas and the society of gynecologic oncology. Gynecol Oncol. 2014 Dec; 135(3):580-2. PMID: 25308928.
      Citations:    
    20. Ali MW, Cacan E, Liu Y, Pierce JY, Creasman WT, Murph MM, Govindarajan R, Eblen ST, Greer SF, Hooks SB. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells. PLoS One. 2013; 8(3):e60185. PMID: 23533674.
      Citations:    
    21. Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol. 2013 May; 129(2):277-84. PMID: 23485770.
      Citations:    
    22. Billingsley CC, Kohler MF, Creasman WT, Madory JE, Young JL. A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis. 2012 Apr; 16(2):145-8. PMID: 22227838.
      Citations:    
    23. Creasman WT. What is the significance of gynecologic symptoms in the participants in the NSABP study? Am J Obstet Gynecol. 2011 Dec; 205(6):511-2. PMID: 22114938.
      Citations:    
    24. Creasman WT. The current status of lymphadenectomy in the management of endometrial cancer. Womens Health (Lond). 2011 Jan; 7(1):33-5. PMID: 21175388.
      Citations:    
    25. Creasman WT, DiSaia PJ. Hormone replacement and breast cancer risk: reconsidering the data. Oncology (Williston Park). 2009 Nov 15; 23(12):1099-100; author reply 1100, 1102. PMID: 20017294.
      Citations:    
    26. Creasman WT, Mutch DE, Herzog TJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol. 2010 Mar; 116(3):293-4. PMID: 19897230.
      Citations:    
    27. Creasman WT, Kohler M, Korte JE. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3. PMID: 19539891.
      Citations:    
    28. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009 May; 105(2):109. PMID: 19345353.
      Citations:    
    29. Batchelor EC, Watkins JM, Creasman WT, Kohler MF, Sinha D, Jenrette JM. The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8. PMID: 18774213.
      Citations:    
    30. Sapp H, Goetzl L, Creasman W, Kohler M, Underwood P, Esnaola N. Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7. PMID: 18565488.
      Citations:    
    31. Kohler MF, Creasman WT. Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium. Future Oncol. 2008 Jun; 4(3):379-87. PMID: 18518763.
      Citations:    
    32. Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet. 2008 May; 101(2):205-10. PMID: 18199437.
      Citations:    
    33. Eddy GL, Bundy BN, Creasman WT, Spirtos NM, Mannel RS, Hannigan E, O'Connor D. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007 Aug; 106(2):362-9. PMID: 17493669.
      Citations:    
    34. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103. PMID: 17161167.
      Citations:    
    35. Beller U, Benedet JL, Creasman WT, Ngan HY, Quinn MA, Maisonneuve P, Pecorelli S, Odicino F, Heintz AP. Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S29-42. PMID: 17161165.
      Citations:    
    36. Beller U, Benedet JL, Creasman WT, Ngan H, Quinn MA, Maisonneuve P, Pecorelli S, Odicino F, Heintz A. Carcinoma of the Vagina. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S29-S42. PMID: 29644658.
      Citations:    
    37. Heintz A, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan H, Pecorelli S, Beller U. Carcinoma of the Fallopian Tube. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S145-S160. PMID: 29644662.
      Citations:    
    38. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz A, Ngan H, Pecorelli S. Carcinoma of the Corpus Uteri. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S105-S143. PMID: 29644661.
      Citations:    
    39. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz A, Ngan H, Pecorelli S. Carcinoma of the Cervix Uteri. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-S103. PMID: 29644676.
      Citations:    
    40. Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan H, Maisonneuve P, Pecorelli S, Odicino F, Heintz A. Carcinoma of the Vulva. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S7-S27. PMID: 29644673.
      Citations:    
    41. Heintz A, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan H, Pecorelli S, Beller U. Carcinoma of the Ovary. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S161-S192. PMID: 29644669.
      Citations:    
    42. Ngan H, Odicino F, Maisonneuve P, Creasman WT, Beller U, Quinn MA, Heintz A, Pecorelli S, Benedet JL. Gestational Trophoblastic Neoplasia. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S193-S203. PMID: 29644675.
      Citations:    
    43. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S145-60. PMID: 17161156.
      Citations:    
    44. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S105-43. PMID: 17161155.
      Citations:    
    45. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S161-92. PMID: 17161157.
      Citations:    
    46. Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Maisonneuve P, Pecorelli S, Odicino F, Heintz AP. Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S7-27. PMID: 17161169.
      Citations:    
    47. Ngan HY, Odicino F, Maisonneuve P, Creasman WT, Beller U, Quinn MA, Heintz AP, Pecorelli S, Benedet JL. Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S193-203. PMID: 17161158.
      Citations:    
    48. Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NE, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed. 2006; 8(2):1 p preceding 35. PMID: 17048337.
      Citations:    
    49. Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed. 2006; 8(3):40. PMID: 17410686.
      Citations:    
    50. Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M, Creasman WT. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. Gynecol Oncol. 2005 Sep; 98(3):467-83. PMID: 15982726.
      Citations:    
    51. Creasman WT. Hormone replacement therapy after cancers. Curr Opin Oncol. 2005 Sep; 17(5):493-9. PMID: 16093802.
      Citations:    
    52. Creasman WT. Breast cancer: the role of hormone therapy. Semin Reprod Med. 2005 May; 23(2):167-71. PMID: 15852202.
      Citations:    
    53. Creasman WT. Vaginal cancers. Curr Opin Obstet Gynecol. 2005 Feb; 17(1):71-6. PMID: 15711415.
      Citations:    
    54. Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004 Dec; 95(3):593-6. PMID: 15581969.
      Citations:    
    55. Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol. 2004 Feb; 92(2):525-9. PMID: 14766243.
      Citations:    
    56. Mathur SP, Mathur RS, Underwood PB, Kohler MF, Creasman WT. Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93. PMID: 14675666.
      Citations:    
    57. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Pecorelli S. Carcinoma of the Fallopian tube. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:119-33. PMID: 14763171.
      Citations:    
    58. Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:79-118. PMID: 14763170.
      Citations:    
    59. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Pecorelli S. Carcinoma of the ovary. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:135-66. PMID: 14763172.
      Citations:    
    60. Beller U, Maisonneuve P, Benedet JL, Heintz AP, Ngan HY, Pecorelli S, Odicino F, Creasman WT. Carcinoma of the vagina. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:27-39. PMID: 14763168.
      Citations:    
    61. Beller U, Maisonneuve P, Benedet JL, Heintz AP, Ngan HY, Pecorelli S, Odicino F, Creasman WT. Carcinoma of the vulva. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:7-26. PMID: 14763167.
      Citations:    
    62. Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S. Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:41-78. PMID: 14763169.
      Citations:    
    63. Ngan HY, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Pecorelli S, Creasman WT. Gestational trophoblastic diseases. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:167-74. PMID: 14763173.
      Citations:    
    64. Creasman WT, Hoel D, Disaia PJ. WHI: Now that the dust has settled: a commentary. Am J Obstet Gynecol. 2003 Sep; 189(3):621-6. PMID: 14526278.
      Citations:    
    65. Landen CN, Mathur SP, Richardson MS, Creasman WT. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 2003 May; 188(5):1174-6. PMID: 12748469.
      Citations:    
    66. Creasman WT. Estrogen and cancer. Gynecol Oncol. 2002 Jul; 86(1):1-9. PMID: 12079291.
      Citations:    
    67. Plaxe SC, Blessing JA, Bookman MA, Creasman WT. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2002 Jan; 84(1):32-5. PMID: 11748972.
      Citations:    
    68. Yakout HH, Bissada NK, Fahmy W, Creasman W, Fraig M, Hull GW. Synchronous bilateral chromophobe cell renal carcinoma. J Urol. 2001 Nov; 166(5):1826. PMID: 11586235.
      Citations:    
    69. Creasman WT. Is this a way to choose a chair? Acad Med. 2001 Oct; 76(10):1032-4. PMID: 11597842.
      Citations:    
    70. Creasman WT. Cancer and pregnancy. Ann N Y Acad Sci. 2001 Sep; 943:281-6. PMID: 11594548.
      Citations:    
    71. Hurteau JA, Blessing JA, DeCesare SL, Creasman WT. Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study. Gynecol Oncol. 2001 Jul; 82(1):7-10. PMID: 11426954.
      Citations:    
    72. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Sideri M, Pecorelli S. Carcinoma of the Fallopian tube. J Epidemiol Biostat. 2001; 6(1):89-103. PMID: 11385778.
      Citations:    
    73. Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Sideri M, Pecorelli S. Carcinoma of the cervix uteri. J Epidemiol Biostat. 2001; 6(1):7-43. PMID: 11385777.
      Citations:    
    74. Beller U, Sideri M, Maisonneuve P, Benedet JL, Heintz AP, Ngan HY, Pecorelli S, Odicino F, Creasman WT. Carcinoma of the vulva. J Epidemiol Biostat. 2001; 6(1):155-73. PMID: 11385774.
      Citations:    
    75. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Sideri M, Pecorelli S. Carcinoma of the ovary. J Epidemiol Biostat. 2001; 6(1):107-38. PMID: 11385772.
      Citations:    
    76. Ngan HY, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Pecorelli S, Sideri M, Creasman WT. Gestational trophoblastic diseases. J Epidemiol Biostat. 2001; 6(1):177-84. PMID: 11385775.
      Citations:    
    77. Beller U, Sideri M, Maisonneuve P, Benedet JL, Heintz AP, Ngan HY, Pecorelli S, Odicino F, Creasman WT. Carcinoma of the vagina. J Epidemiol Biostat. 2001; 6(1):141-52. PMID: 11385773.
      Citations:    
    78. Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Sideri M, Pecorelli S. Carcinoma of the corpus uteri. J Epidemiol Biostat. 2001; 6(1):47-86. PMID: 11385776.
      Citations:    
    79. Geier CS, Wilson M, Creasman W. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol. 2001 Jan; 184(2):64-9. PMID: 11174481.
      Citations:    
    80. Creasman WT. Stage IA cancer of the cervix: finally some resolution of definition and treatment? Gynecol Oncol. 1999 Aug; 74(2):163-4. PMID: 10419726.
      Citations:    
    81. Creasman WT, DeGeest K, DiSaia PJ, Zaino RJ. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1999 Jul; 181(1):31-4. PMID: 10411790.
      Citations:    
    82. Brewster WR, DiSaia PJ, Grosen EA, McGonigle KF, Kuykendall JL, Creasman WT. An experience with estrogen replacement therapy in breast cancer survivors. Int J Fertil Womens Med. 1999 Jun-Aug; 44(4):186-92. PMID: 10499739.
      Citations:    
    83. Creasman WT, Phillips JL, Menck HR. A survey of hospital management practices for vulvar melanoma. J Am Coll Surg. 1999 Jun; 188(6):670-5. PMID: 10359360.
      Citations:    
    84. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. 1999 Jun; 65(3):243-9. PMID: 10428343.
      Citations:    
    85. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. 1999 Jan; 64(1):5-10. PMID: 10190664.
      Citations:    
    86. Creasman WT. HRT and women who have had breast or endometrial cancer. J Epidemiol Biostat. 1999; 4(3):217-20; discussion 221-5. PMID: 10695960.
      Citations:    
    87. Creasman WT. Is there an association between hormone replacement therapy and breast cancer? J Womens Health. 1998 Dec; 7(10):1231-46. PMID: 9929856.
      Citations:    
    88. Creasman WT, Phillips JL, Menck HR. The National Cancer Data Base report on cancer of the vagina. Cancer. 1998 Sep 01; 83(5):1033-40. PMID: 9731908.
      Citations:    
    89. Creasman WT, Zaino RJ, Major FJ, DiSaia PJ, Hatch KD, Homesley HD. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1998 Jan; 178(1 Pt 1):62-5. PMID: 9465805.
      Citations:    
    90. Creasman WT, Phillips JL, Menck HR. The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1997 Aug 01; 80(3):505-13. PMID: 9241085.
      Citations:    
    91. Williams L, Brunetto VL, Yordan E, DiSaia PJ, Creasman WT. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study. Gynecol Oncol. 1997 Aug; 66(2):171-8. PMID: 9264559.
      Citations:    
    92. Creasman WT. Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol. 1997 Feb; 24(1 Suppl 1):S1-140-S1-50. PMID: 9045311.
      Citations:    
    93. Rose PG, Blessing JA, Lewandowski GS, Creasman WT, Webster KD. A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Oct; 63(1):101-4. PMID: 8898177.
      Citations:    
    94. Markman M, Iseminger KA, Hatch KD, Creasman WT, Barnes W, Dubeshter B. Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report. Gynecol Oncol. 1996 Jul; 62(1):4-6. PMID: 8690289.
      Citations:    
    95. DiSaia PJ, Grosen EA, Odicino F, Cowan B, Pecorelli S, Wile AG, Creasman WT. Replacement therapy for breast cancer survivors. A pilot study. Cancer. 1995 Nov 15; 76(10 Suppl):2075-8. PMID: 8635003.
      Citations:    
    96. Creasman WT. New gynecologic cancer staging. Gynecol Oncol. 1995 Aug; 58(2):157-8. PMID: 7622099.
      Citations:    
    97. McGuire WP, Hoskins WJ, Brady MF, Homesley HD, Creasman WT, Berman ML, Ball H, Berek JS, Woodward J. Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 1995 Jul; 13(7):1589-99. PMID: 7602348.
      Citations:    
    98. Eddy GL, Manetta A, Alvarez RD, Williams L, Creasman WT. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol. 1995 Jun; 57(3):412-6. PMID: 7774847.
      Citations:    
    99. Mackey SE, Creasman WT. Ovarian cancer screening. J Clin Oncol. 1995 Mar; 13(3):783-93. PMID: 7884436.
      Citations:    
    100. Creasman WT. Second-look laparotomy in ovarian cancer. Gynecol Oncol. 1994 Dec; 55(3 Pt 2):S122-7. PMID: 7835795.
      Citations:    
    101. Eddy GL, Spiegel GW, Creasman WT. Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two cases. Gynecol Oncol. 1994 Nov; 55(2):313-7. PMID: 7959301.
      Citations:    
    102. Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, Ball H, Berek JS. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994 Apr; 170(4):974-9; discussion 979-80. PMID: 8166218.
      Citations:    
    103. Creasman WT. Limited disease: role of surgery. Semin Oncol. 1994 Feb; 21(1):79-83. PMID: 8310313.
      Citations:    
    104. DiSaia PJ, Creasman WT, Eddy G, Montz J. Experience with a mass closure technique using continuous looped polyglyconate absorbable suture. J Am Coll Surg. 1994 Feb; 178(2):177-80. PMID: 8173732.
      Citations:    
    105. Eddy GL, Jenrette JM, Creasman WT. Effect of radiotherapeutic technique on local control in primary vaginal carcinoma. Int J Gynecol Cancer. 1993 Nov; 3(6):399-404. PMID: 11578376.
      Citations:    
    106. Stehman FB, Bundy BN, Thomas G, Keys HM, d'Ablaing G, Fowler WC, Mortel R, Creasman WT. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993 Aug; 11(8):1523-8. PMID: 8336190.
      Citations:    
    107. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer. 1993 Feb 15; 71(4 Suppl):1467-70. PMID: 8431882.
      Citations:    
    108. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993 Feb 15; 71(4 Suppl):1702-9. PMID: 8381710.
      Citations:    
    109. Creasman WT. Adenocarcinoma of the uterine corpus. Curr Opin Obstet Gynecol. 1993 Feb; 5(1):80-3. PMID: 8425039.
      Citations:    
    110. Thigpen T, Brady MF, Omura GA, Creasman WT, McGuire WP, Hoskins WJ, Williams S. Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience. Cancer. 1993 Jan 15; 71(2 Suppl):606-14. PMID: 8420683.
      Citations:    
    111. Creasman WT. Revision in classification by International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol. 1992 Sep; 167(3):857-8. PMID: 1326895.
      Citations:    
    112. Creasman WT. Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer. Oncology (Williston Park). 1992 Jul; 6(7):23-6; discussion 26, 28. PMID: 1386238.
      Citations:    
    113. Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992 Apr; 79(4):490-7. PMID: 1553164.
      Citations:    
    114. Sutton GP, Bundy BN, Delgado G, Sevin BU, Creasman WT, Major FJ, Zaino R. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1992 Jan; 166(1 Pt 1):50-3. PMID: 1733218.
      Citations:    
    115. Massad LS, Hunter VJ, Szpak CA, Clarke-Pearson DL, Creasman WT. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol. 1991 Dec; 78(6):1027-32. PMID: 1945202.
      Citations:    
    116. Bast RC, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, Soper J, Creasman W, Gall S, Knapp RC, et al. Coordinate elevation of serum markers in ovarian cancer but not in benign disease. Cancer. 1991 Oct 15; 68(8):1758-63. PMID: 1913520.
      Citations:    
    117. Hatch KD, Beecham JB, Blessing JA, Creasman WT. Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients. Cancer. 1991 Jul 15; 68(2):269-71. PMID: 2070324.
      Citations:    
    118. Creasman WT, DiSaia PJ. Screening in ovarian cancer. Am J Obstet Gynecol. 1991 Jul; 165(1):7-10. PMID: 1853918.
      Citations:    
    119. Creasman WT. Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol. 1991 Feb; 77(2):308-12. PMID: 1988899.
      Citations:    
    120. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991 Jan; 40(1):55-65. PMID: 1989916.
      Citations:    
    121. Montz FJ, Creasman WT, Eddy G, Disaia PJ. Running mass closure of abdominal wounds using absorbable looped suture. J Gynecol Surg. 1991; 7(2):107-10. PMID: 10149779.
      Citations:    
    122. Hughes CL, Wall LL, Creasman WT. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol. 1991 Jan; 40(1):42-5. PMID: 1824939.
      Citations:    
    123. Sokoll WC, Creasman WT. Is laser surgery superior to cryosurgery for the treatment of high grade CIN? Con. J Gynecol Surg. 1991; 7(1):57-9. PMID: 10149775.
      Citations:    
    124. Creasman WT, Omura GA, Brady MF, Yordan E, DiSaia PJ, Beecham J. A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 1990 Dec; 39(3):239-43. PMID: 2258063.
      Citations:    
    125. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990 Sep; 38(3):352-7. PMID: 2227547.
      Citations:    
    126. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990 Jun; 37(3):390-5. PMID: 2351324.
      Citations:    
    127. Clark-Pearson DL, DeLong E, Synan IS, Soper JT, Creasman WT, Coleman RE. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol. 1990 Apr; 75(4):684-9. PMID: 2179782.
      Citations:    
    128. Soper JT, Segreti EM, Novotny DB, Mutch D, Creasman WT, McCarty KS. Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis. Gynecol Oncol. 1990 Mar; 36(3):363-8. PMID: 2318445.
      Citations:    
    129. Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC. Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstet Gynecol. 1990 Feb; 75(2):249-54. PMID: 2300353.
      Citations:    
    130. Morrow CP, Bundy BN, Homesley HD, Creasman WT, Hornback NB, Kurman R, Thigpen JT. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. Gynecol Oncol. 1990 Feb; 36(2):166-71. PMID: 2298404.
      Citations:    
    131. Creasman WT. New gynecologic cancer staging. Obstet Gynecol. 1990 Feb; 75(2):287-8. PMID: 2300358.
      Citations:    
    132. Creasman WT, Eddy GL. Recent advances in endometrial cancer. Semin Surg Oncol. 1990; 6(6):339-42. PMID: 2263809.
      Citations:    
    133. Creasman WT, Gall S, Bundy BN, Beecham J, Mortel R, Homesley HD. Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). Gynecol Oncol. 1989 Dec; 35(3):378-82. PMID: 2599475.
      Citations:    
    134. Delgado G, Bundy BN, Fowler WC, Stehman FB, Sevin B, Creasman WT, Major F, DiSaia P, Zaino R. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Dec; 35(3):314-20. PMID: 2599466.
      Citations:    
    135. Berman ML, Soper JT, Creasman WT, Olt GT, DiSaia PJ. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol. 1989 Dec; 35(3):352-7. PMID: 2599471.
      Citations:    
    136. McGuire WP, Arseneau J, Blessing JA, DiSaia PJ, Hatch KD, Given FT, Teng NN, Creasman WT. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1989 Oct; 7(10):1462-8. PMID: 2674333.
      Citations:    
    137. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol. 1989 Oct; 35(1):93-8. PMID: 2792911.
      Citations:    
    138. Creasman WT. How good (or bad) is the Pap smear? J S C Med Assoc. 1989 Oct; 85(10):459-62. PMID: 2811306.
      Citations:    
    139. Creasman WT. One score + 11 = 2000. Gynecol Oncol. 1989 Sep; 34(3):255-7. PMID: 2767516.
      Citations:    
    140. Segreti EM, Novotny DB, Soper JT, Mutch DG, Creasman WT, McCarty KS. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor. Obstet Gynecol. 1989 May; 73(5 Pt 1):780-5. PMID: 2704506.
      Citations:    
    141. Thigpen JT, Blessing JA, Homesley H, Creasman WT, Sutton G. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Apr; 33(1):68-70. PMID: 2703169.
      Citations:    
    142. Creasman WT, Eddy GL. Prognostic factors in relation to second-look laparotomy in ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989 Mar; 3(1):183-90. PMID: 2661092.
      Citations:    
    143. Stehman FB, Bundy BN, Keys H, Currie JL, Mortel R, Creasman WT. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1988 Jul; 159(1):87-94. PMID: 3293456.
      Citations:    
    144. Soper JT, Blaszczyk TM, Oke E, Clarke-Pearson D, Creasman WT. Percutaneous nephrostomy in gynecologic oncology patients. Am J Obstet Gynecol. 1988 May; 158(5):1126-31. PMID: 2453117.
      Citations:    
    145. Soper JT, Clarke-Pearson DL, Creasman WT. Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies. Gynecol Oncol. 1988 Mar; 29(3):283-9. PMID: 3345950.
      Citations:    
    146. Clarke-Pearson DL, DeLong ER, Chin N, Rice R, Creasman WT. Intestinal obstruction in patients with ovarian cancer. Variables associated with surgical complications and survival. Arch Surg. 1988 Jan; 123(1):42-5. PMID: 3337655.
      Citations:    
    147. Clarke-Pearson DL, Soper JT, Creasman WT. Absorbable synthetic mesh (polyglactin 910) for the formation of a pelvic "lid" after radical pelvic resection. Am J Obstet Gynecol. 1988 Jan; 158(1):158-61. PMID: 3337163.
      Citations:    
    148. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987 Oct 15; 60(8 Suppl):2035-41. PMID: 3652025.
      Citations:    
    149. Mutch DG, Soper JT, Budwit-Novotny DA, Cox EB, Creasman WT, McCarty KS, McCarty KS. Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods. Am J Obstet Gynecol. 1987 Oct; 157(4 Pt 1):924-31. PMID: 3314520.
      Citations:    
    150. Barter JF, Szpak C, Creasman WT. Uterine leiomyomas with retroperitoneal lymph node involvement. South Med J. 1987 Oct; 80(10):1320-2. PMID: 3660051.
      Citations:    
    151. Jones DE, Creasman WT, Dombroski RA, Lentz SS, Waeltz JL. Evaluation of the atypical Pap smear. Am J Obstet Gynecol. 1987 Sep; 157(3):544-9. PMID: 3631155.
      Citations:    
    152. Soper JT, Cox EB, Budwit-Novotny D, Mutch DG, Creasman WT, McCarty KS, McCarty KS. Histologic composition of endometrial carcinomas analyzed for steroid receptor content. Am J Obstet Gynecol. 1987 Jul; 157(1):26-7. PMID: 3605264.
      Citations:    
    153. Soper JT, Wilkinson RH, Bandy LC, Clarke-Pearson DL, Creasman WT. Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging. Am J Obstet Gynecol. 1987 May; 156(5):1153-8. PMID: 3578429.
      Citations:    
    154. Bearman DM, MacMillan JP, Creasman WT. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols. Obstet Gynecol. 1987 Feb; 69(2):151-5. PMID: 3808501.
      Citations:    
    155. Bandy LC, Clarke-Pearson DL, Soper JT, Mutch DG, MacMillan J, Creasman WT. Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation. Gynecol Oncol. 1987 Feb; 26(2):160-8. PMID: 3804034.
      Citations:    
    156. Clarke-Pearson DL, Chin NO, DeLong ER, Rice R, Creasman WT. Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival. Gynecol Oncol. 1987 Jan; 26(1):11-8. PMID: 2431962.
      Citations:    
    157. DiSaia PJ, Creasman WT. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy. Clin Obstet Gynaecol. 1986 Dec; 13(4):751-65. PMID: 3791829.
      Citations:    
    158. Creasman WT, Soper JT, Clarke-Pearson D. Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol. 1986 Nov; 155(5):964-9. PMID: 3777072.
      Citations:    
    159. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty KS. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986 Oct; 46(10):5419-25. PMID: 3756890.
      Citations:    
    160. Geszler G, Szpak CA, Harris RE, Creasman WT, Barter JF, Johnston WW. Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterus. Am J Obstet Gynecol. 1986 Jul; 155(1):83-9. PMID: 3014883.
      Citations:    
    161. Omura G, Blessing JA, Ehrlich CE, Miller A, Yordan E, Creasman WT, Homesley HD. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer. 1986 May 01; 57(9):1725-30. PMID: 3513943.
      Citations:    
    162. Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol. 1986 Mar; 67(3):326-30. PMID: 3003636.
      Citations:    
    163. Thigpen JT, Blessing JA, Homesley HD, Berek JS, Creasman WT. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. Gynecol Oncol. 1986 Jan; 23(1):101-4. PMID: 3943746.
      Citations:    
    164. Puleo JG, Clarke-Pearson DL, Smith EB, Barnard DE, Creasman WT. Superior vena cava syndrome associated with gynecologic malignancy. Gynecol Oncol. 1986 Jan; 23(1):59-64. PMID: 3943753.
      Citations:    
    165. Creasman WT, Soper JT. Assessment of the contemporary management of germ cell malignancies of the ovary. Am J Obstet Gynecol. 1985 Dec 15; 153(8):828-34. PMID: 3000182.
      Citations:    
    166. Soper JT, McCarty KS, Creasman WT, McCarty KS. Histologic control of biochemical steroid receptor analysis in endometrial carcinomas. Am J Obstet Gynecol. 1985 Nov 01; 153(5):520-3. PMID: 4061513.
      Citations:    
    167. Soper JT, Creasman WT, Clarke-Pearson DL, Sullivan DC, Vergadoro F, Johnston WW. Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol. 1985 Sep 15; 153(2):191-6. PMID: 4037013.
      Citations:    
    168. Creasman WT, Fetter BF, Clarke-Pearson DL, Kaufmann L, Parker RT. Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol. 1985 Sep 15; 153(2):164-72. PMID: 4037011.
      Citations:    
    169. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report). Cancer. 1985 Jul 15; 56(2):243-8. PMID: 2988740.
      Citations:    
    170. Abdulhay G, DiSaia PJ, Blessing JA, Creasman WT. Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1985 Jun 15; 152(4):418-23. PMID: 4040329.
      Citations:    
    171. Barter JF, Smith EB, Szpak CA, Hinshaw W, Clarke-Pearson DL, Creasman WT. Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. Gynecol Oncol. 1985 Jun; 21(2):220-7. PMID: 3988135.
      Citations:    
    172. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985 Apr 15; 151(8):1009-15. PMID: 3985062.
      Citations:    
    173. Muss HB, Bundy B, DiSaia PJ, Homesley HD, Fowler WC, Creasman W, Yordan E. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group). Cancer. 1985 Apr 15; 55(8):1648-53. PMID: 3884128.
      Citations:    
    174. Creasman WT, Soper JT, McCarty KS, McCarty KS, Hinshaw W, Clarke-Pearson DL. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol. 1985 Apr 01; 151(7):922-32. PMID: 3985057.
      Citations:    
    175. Bandy LC, Clarke-Pearson DL, Silverman PM, Creasman WT. Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix. Obstet Gynecol. 1985 Jan; 65(1):73-6. PMID: 3966026.
      Citations:    
    176. Smith EB, Clarke-Pearson DL, Creasman WT. A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies. Am J Obstet Gynecol. 1984 Dec 15; 150(8):927-31. PMID: 6542313.
      Citations:    
    177. Soper JT, McCarty KS, Creasman WT, Clarke-Pearson DL, McCarty KS. Induction of cytoplasmic progesterone receptor in human endometrial carcinoma transplanted into nude mice. Am J Obstet Gynecol. 1984 Oct 15; 150(4):437-9. PMID: 6486209.
      Citations:    
    178. Soper JT, McCarty KS, Hinshaw W, Creasman WT, McCarty KS, Clarke-Pearson DL. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. Am J Obstet Gynecol. 1984 Oct 15; 150(4):342-8. PMID: 6486200.
      Citations:    
    179. Berman ML, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984 Sep; 19(1):8-16. PMID: 6469092.
      Citations:    
    180. Clarke-Pearson DL, Coleman RE, Petry N, Synan IS, Creasman WT. Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: a case report. Am J Obstet Gynecol. 1984 Aug 01; 149(7):796-8. PMID: 6465234.
      Citations:    
    181. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984 Jun; 63(6):825-32. PMID: 6728365.
      Citations:    
    182. Muss HB, Slavik M, Bundy B, Stehman FB, Creasman WT. A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol. 1984 Jun; 7(3):257-60. PMID: 6731346.
      Citations:    
    183. Clarke-Pearson DL, Creasman WT, Coleman RE, Synan IS, Hinshaw WM. Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. Gynecol Oncol. 1984 Jun; 18(2):226-32. PMID: 6376294.
      Citations:    
    184. Slavik M, Petty WM, Blessing JA, Creasman WT, Homesley HD. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer Treat Rep. 1984 May; 68(5):809-11. PMID: 6722836.
      Citations:    
    185. Clarke-Pearson DL, Synan IS, Colemen RE, Hinshaw W, Creasman WT. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol. 1984 Apr 15; 148(8):1051-4. PMID: 6711637.
      Citations:    
    186. Bandy LC, Clarke-Pearson DL, Creasman WT. Vitamin-B12 deficiency following therapy in gynecologic oncology. Gynecol Oncol. 1984 Mar; 17(3):370-4. PMID: 6706235.
      Citations:    
    187. Abu-Ghazaleh S, Johnston W, Creasman WT. The significance of peritoneal cytology in patients with carcinoma of the cervix. Gynecol Oncol. 1984 Feb; 17(2):139-48. PMID: 6368330.
      Citations:    
    188. Creasman WT, Hinshaw WM, Clarke-Pearson DL. Cryosurgery in the management of cervical intraepithelial neoplasia. Obstet Gynecol. 1984 Feb; 63(2):145-9. PMID: 6694806.
      Citations:    
    189. Clarke-Pearson DL, Synan IS, Creasman WT. Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy. Am J Obstet Gynecol. 1983 Oct 15; 147(4):369-75. PMID: 6624807.
      Citations:    
    190. Figge DC, Creasman WT. Cryotherapy in the treatment of cervical intraepithelial neoplasia. Obstet Gynecol. 1983 Sep; 62(3):353-8. PMID: 6348614.
      Citations:    
    191. Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT, Zaino RJ. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 1983 Aug 15; 52(4):626-32. PMID: 6344983.
      Citations:    
    192. Currie JL, Gall S, Weed JC, Creasman WT. Intracavitary Corynebacterium parvum for treatment of malignant effusions. Gynecol Oncol. 1983 Aug; 16(1):6-14. PMID: 6884832.
      Citations:    
    193. Thigpen JT, Ehrlich CE, Creasman WT, Curry S, Blessing JA. Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study. Am J Clin Oncol. 1983 Jun; 6(3):273-5. PMID: 6846245.
      Citations:    
    194. Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol. 1983 Mar 01; 145(5):606-13. PMID: 6338722.
      Citations:    
    195. Clarke-Pearson DL, Jelovsek FR, Creasman WT. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis. Obstet Gynecol. 1983 Jan; 61(1):87-94. PMID: 6823353.
      Citations:    
    196. Johnston WW, Myers B, Creasman WT, Owens SM. Cytopathology and the management of early invasive cancer of the uterine cervix. Obstet Gynecol. 1982 Sep; 60(3):350-3. PMID: 7121916.
      Citations:    
    197. Clayton LA, Gall SA, Dawson JR, Creasman WT. Immune complexes in ovarian cancer. Gynecol Oncol. 1982 Apr; 13(2):203-12. PMID: 7076036.
      Citations:    
    198. Creasman WT, Hill GB, Weed JC, Gall SA. A trial of prophylactic cefamandole in extended gynecologic surgery. Obstet Gynecol. 1982 Mar; 59(3):309-14. PMID: 7043340.
      Citations:    
    199. Clarke-Pearson DL, Synan IS, Creasman WT. Significant venous thromboembolism caused by pelvic lymphocysts: diagnosis and management. Gynecol Oncol. 1982 Feb; 13(1):136-43. PMID: 7060988.
      Citations:    
    200. Creasman WT, Park R, Norris H, Disaia PJ, Morrow CP, Hreshchyshyn MM. Stage I borderline ovarian tumors. Obstet Gynecol. 1982 Jan; 59(1):93-6. PMID: 7078855.
      Citations:    
    201. Creasman WT, Disaia PJ, Blessing J, Wilkinson RH, Johnston W, Weed JC. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol. 1981 Dec 15; 141(8):921-9. PMID: 7315922.
      Citations:    
    202. Creasman WT, Sasso RA, Weed JC, McCarty KS. Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding. Gynecol Oncol. 1981 Dec; 12(3):319-27. PMID: 6171488.
      Citations:    
    203. Szpak CA, Creasman WT, Vollmer RT, Johnston WW. Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma. Acta Cytol. 1981 Nov-Dec; 25(6):640-6. PMID: 6171978.
      Citations:    
    204. Creasman WT, Clarke-Pearson DL, Weed JC. Results of outpatient therapy of cervical intraepithelial neoplasia. Gynecol Oncol. 1981 Oct; 12(2 Pt 2):S306-16. PMID: 7308862.
      Citations:    
    205. Currie JL, Bagne F, Harris C, Sullivan DL, Surwit EA, Wilkinson RH, Creasman WT. Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients. Gynecol Oncol. 1981 Oct; 12(2 Pt 1):193-218. PMID: 7297930.
      Citations:    
    206. Creasman WT, Clarke-Pearson DL, Ashe C, Weed JC. The abnormal Pap smear--what to do next? Cancer. 1981 Jul 15; 48(2 Suppl):515-22. PMID: 7272976.
      Citations:    
    207. Hreshchyshyn MM, Park RC, Blessing JA, Norris HJ, Levy D, Lagasse LD, Creasman WT. The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol. 1980 Sep 15; 138(2):139-45. PMID: 6252780.
      Citations:    
    208. Creasman WT, Weed JC. Cancer of the endometrium. Curr Probl Cancer. 1980 Aug; 5(2):1-33. PMID: 7408531.
      Citations:    
    209. Jelovsek FR, Hammond CB, Woodard BH, Draffin R, Lee KL, Creasman WT, Parker RT. Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol. 1980 May 01; 137(1):85-91. PMID: 7369293.
      Citations:    
    210. Creasman WT, McCarty KS, Barton TK, McCarty KS. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol. 1980 Mar; 55(3):363-70. PMID: 7189047.
      Citations:    
    211. Creasman WT, Weed JC. Conservative management of cervical intraepithelial neoplasia. Clin Obstet Gynecol. 1980 Mar; 23(1):281-91. PMID: 6988130.
      Citations:    
    212. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980 Feb; 9(1):90-8. PMID: 7353805.
      Citations:    
    213. Slayton RE, Creasman WT, Petty W, Bundy B, Blessing JA. Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):2089-92. PMID: 526942.
      Citations:    
    214. Sall S, DiSaia P, Morrow CP, Mortel R, Prem K, Thigpen T, Creasman W. A comparison of medroxyprogesterone serum concentrations by the oral or intramuscular route in patients with persistent or recurrent endometrial carcinoma. Am J Obstet Gynecol. 1979 Nov 01; 135(5):647-50. PMID: 507117.
      Citations:    
    215. McCarty KS, Barton TK, Fetter BF, Creasman WT, McCarty KS. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am J Pathol. 1979 Jul; 96(1):171-83. PMID: 464018.
      Citations:    
    216. Abu-Ghazaleh SZ, Creasman WT. Unusual metastasis in carcinoma of the cervix uteri. Surg Gynecol Obstet. 1979 May; 148(5):728-30. PMID: 107604.
      Citations:    
    217. DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol. 1979 Apr 01; 133(7):825-32. PMID: 434024.
      Citations:    
    218. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol. 1979 Mar 01; 133(5):537-47. PMID: 220875.
      Citations:    
    219. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 1979 Mar 01; 133(5):525-36. PMID: 443293.
      Citations:    
    220. Surwit EA, Fowler WC, Rogoff EE, Jelovsek F, Parker RT, Creasman WT. Stage II carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1979 Mar; 5(3):323-6. PMID: 457477.
      Citations:    
    221. Creasman WT, Gall SA, Blessing JA, Schmidt HJ, Abu-Ghazaleh S, Whisnant JK, DiSaia PJ. Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study. Cancer Treat Rep. 1979 Feb; 63(2):319-23. PMID: 445505.
      Citations:    
    222. Gall SA, DiSaia PJ, Schmidt H, Mittelstaedt L, Newman P, Creasman W. Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma. Am J Obstet Gynecol. 1978 Nov 01; 132(5):555-60. PMID: 717456.
      Citations:    
    223. Creasman WT, Abu-Ghazaleh S, Schmidt HJ. Retroperitoneal metastatic spread of ovarian cancer. Gynecol Oncol. 1978 Oct; 6(5):447-50. PMID: 738622.
      Citations:    
    224. Omura GA, Shingleton HM, Creasman WT, Blessing JA, Boronow RC. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. Cancer Treat Rep. 1978 May; 62(5):833-5. PMID: 350400.
      Citations:    
    225. DiSaia PJ, Morrow CP, Boronow R, Creasman W, Mittelstaedt L. Endometrial sarcoma: lymphatic spread pattern. Am J Obstet Gynecol. 1978 Jan 01; 130(1):104-5. PMID: 619636.
      Citations:    
    226. Creasman WT, Boronow RC, Morrow CP, DiSaia PJ, Blessing J. Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report. Gynecol Oncol. 1976 Sep; 4(3):239-43. PMID: 964690.
      Citations:    
    227. Parker RT, Duncan I, Rampone J, Creasman W. Operative management of early invasive epidermoid carcinoma of the vulva. Am J Obstet Gynecol. 1975 Oct 15; 123(4):349-55. PMID: 1166863.
      Citations:    
    228. Weed JC, Creasman WT. Meningeal carcinomatosis secondary to advanced squamous cell carcinoma of the cervix: a case report. Meningeal metastasis of advenced cervical cancer. Gynecol Oncol. 1975 Sep; 3(3):201-4. PMID: 1193431.
      Citations:    
    229. Creasman WT, Parker RT. Management of early cervical neoplasia. Clin Obstet Gynecol. 1975 Sep; 18(3):233-45. PMID: 1157362.
      Citations:    
    230. Creasman WT, Gallager HS, Rutledge F. Paget's disease of the vulva. Gynecol Oncol. 1975 Jun; 3(2):133-48. PMID: 171199.
      Citations:    
    231. Creasman WT, Rutledge F. Is positive pelvic lymphadenopathy a contraindication to radical surgery in recurrent cervical carcinoma? Gynecol Oncol. 1974 Dec; 2(4):482-5. PMID: 4463149.
      Citations:    
    232. Wilbanks GD, Creasman WT, Kaufmann LA, Parker RT. Treatment of cervical dysplasia with electrocautery and tetracycline suppositories. Am J Obstet Gynecol. 1973 Oct 15; 117(4):460-3. PMID: 4582706.
      Citations:    
    233. Creasman WT, Parker RT. Microinvasive carcinoma of the cervix. Clin Obstet Gynecol. 1973 Jun; 16(2):261-75. PMID: 4713214.
      Citations:    
    234. Creasman WT, Weed JC, Curry SL, Johnston WW, Parker RT. Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia. Obstet Gynecol. 1973 Apr; 41(4):501-6. PMID: 4696965.
      Citations:    
    235. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT. Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol. 1973 Feb 15; 115(4):451-7. PMID: 4346614.
      Citations:    
    236. Creasman WT, Rutledge F. Preoperative evaluation of patients with recurrent carcinoma of the cervix. Gynecol Oncol. 1972 Nov; 1(1):111-8. PMID: 4669438.
      Citations:    
    237. Creasman WT, Lukeman J. Unreliability of urinary cytology in detecting gynecologic malignancy. Cancer. 1972 Jul; 30(1):148-9. PMID: 5040737.
      Citations:    
    238. Creasman WT, Rutledge F. Carcinoma in situ of the cervix. An analysis of 861 patients. Obstet Gynecol. 1972 Mar; 39(3):373-80. PMID: 5019309.
      Citations:    
    239. Henderson SR, Lund CJ, Creasman WT. Antepartum pulmonary embolism. Am J Obstet Gynecol. 1972 Feb 15; 112(4):476-86. PMID: 5008617.
      Citations:    
    240. Creasman WT, Lukeman J. Role of the fallopian tube in dissemination of malignant cells in corpus cancer. Cancer. 1972 Feb; 29(2):456-7. PMID: 5013545.
      Citations:    
    241. Creasman WT, Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol. 1971 Jul 15; 110(6):773-81. PMID: 5561996.
      Citations:    
    242. Creasman WT, Rutledge F, Smith JP. Carcinoma of the ovary associated with pregnancy. Obstet Gynecol. 1971 Jul; 38(1):111-6. PMID: 5561075.
      Citations:    
    243. Creasman WT. Back and hip pain in pregnancy due to chordoma. Am J Obstet Gynecol. 1967 Dec 15; 99(8):1165-6. PMID: 4294346.
      Citations:    
    244. Thiede HA, Creasman WT, Metcalfe S. Antenatal analysis of the human chromosomes. Am J Obstet Gynecol. 1966 Feb 15; 94(4):589-90. PMID: 5948257.
      Citations:    
    245. Creasman WT, Duggan ER, Lund CJ. Absorption of transfused chromium-labeled erythrocytes from the fetal peritoneal cavity in hydrops fetalis. Am J Obstet Gynecol. 1966 Feb 15; 94(4):586-8. PMID: 5948256.
      Citations:    
    Creasman's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (520)
    Explore
    _
    Co-Authors (12)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _